Zhang, C.; Kuo, J.C.-T.; Huang, Y.; Hu, Y.; Deng, L.; Yung, B.C.; Zhao, X.; Zhang, Z.; Pan, J.; Ma, Y.;
et al. Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma. Pharmaceutics 2023, 15, 2674.
https://doi.org/10.3390/pharmaceutics15122674
AMA Style
Zhang C, Kuo JC-T, Huang Y, Hu Y, Deng L, Yung BC, Zhao X, Zhang Z, Pan J, Ma Y,
et al. Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma. Pharmaceutics. 2023; 15(12):2674.
https://doi.org/10.3390/pharmaceutics15122674
Chicago/Turabian Style
Zhang, Chi, Jimmy Chun-Tien Kuo, Yirui Huang, Yingwen Hu, Lan Deng, Bryant C. Yung, Xiaobin Zhao, Zhongkun Zhang, Junjie Pan, Yifan Ma,
and et al. 2023. "Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma" Pharmaceutics 15, no. 12: 2674.
https://doi.org/10.3390/pharmaceutics15122674
APA Style
Zhang, C., Kuo, J. C.-T., Huang, Y., Hu, Y., Deng, L., Yung, B. C., Zhao, X., Zhang, Z., Pan, J., Ma, Y., & Lee, R. J.
(2023). Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma. Pharmaceutics, 15(12), 2674.
https://doi.org/10.3390/pharmaceutics15122674
